查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401914

2030 年神經科學市場預測：按組件、技術最終用戶和地區分類的全球分析

Neuroscience Market Forecasts to 2030 - Global Analysis By Components (Instruments, Consumables and Software and Services), By Technology (Whole Brain Imaging, Neuro-Microscopy, Electrophysiology and Other Technologies) End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球神經科學市場規模將達到 456 億美元，預計到 2030 年將達到 759 億美元，預測期內複合年成長率為 7.5%。

神經科學是神經系統的跨學科研究，探索其結構、功能、發展以及對行為和認知的影響。它涵蓋心理學、生物學和醫學等多個領域，深入研究神經元、神經迴路和大腦過程，以了解感知、記憶、情緒和疾病。神經科學旨在破解大腦和神經系統的複雜性，並揭示指導人類思想和行為的基本原則。

根據美國生物技術資訊中心（NCBI）統計，每年有 2,260 萬人遭受神經損傷和殘疾，其中 1,380 萬人需要手術治療。

腦相關疾病的盛行率不斷增加

大腦相關疾病的盛行率迅速上升，成為推動神經科學市場成長的催化劑。阿茲海默症、帕金森氏症和各種精神疾病等疾病的增加增加了對創新診斷工具、治療方法和療法的需求。這種激增正在刺激神經科學領域的廣泛研究和投資，以揭示大腦的複雜性。此外，先進技術加上對神經機制的深入了解，正在促進有針對性的干涉措施的市場開拓並促進市場擴張。

與特定設備相關的成本

神經科學研究所必需的最尖端科技，例如高解析度成像設備、先進的電生理設備和專門的分析工具，通常成本高。這些經濟障礙阻止小型研究機構、學術機構甚至一些行業相關人員獲得或購買這種關鍵設備。此外，這些工具的成本集中性質可能會增加整體研發成本，影響預算分配，並從其他重要研究領域轉移資源。

神經科學和神經技術的進展

神經科學的不斷發展和突破，加上神經技術創新的快速進步，正在為神經科學市場創造巨大的機會。這些進步為突破性發現鋪平了道路，加深了我們對大腦複雜性及其功能的理解。先進的影像技術、腦機介面和神經調節設備是增強診斷、治療和調查方法的突破性技術。這些進步不僅有助於精確繪製神經網路，還可以對神經系統和大腦相關疾病進行更有針對性的干涉。

動物實驗中的倫理問題

圍繞動物測試的倫理問題對神經科學市場構成了重大威脅。社會對在研究中使用動物的福利和倫理影響的日益關注可能會導致對某些實驗方法的嚴格監管、限制或禁止。這限制了調查方法的範圍，並限制了理解神經機制的潛在途徑。這些限制可能會阻礙科學進步並阻礙治療方法和療法新興市場的開拓，從而限制市場內神經學研究和應用的範圍和深度。

COVID-19 的影響：

COVID-19 大流行對神經科學市場產生了重大影響。由於資源轉移、研究活動中斷以及抗擊病毒的重點縮小，許多神經科學計劃面臨延遲和資金挑戰。神經系統疾病的臨床試驗受到影響，影響了病患招募和資料收集。然而，疫情也刺激了技術創新，凸顯了對遠端醫療解決方案的需求，並加速了神經科學領域數位健康工具的發展。

預計診斷測試部門在預測期內將是最大的

診斷測試部門預計將引領神經科學市場，因為它在神經診斷的進步中發揮關鍵作用。這些實驗室採用基因檢測、生物標記分析等最尖端科技以及 MRI 和 PET 掃描等神經影像技術，可精確識別和了解神經系統疾病。這些實驗室專注於早期檢測和個人化醫療，在提高診斷準確性、評估預後和推進治療方面發揮關鍵作用。此外，全面的測試服務和研究舉措正在推動該領域的擴張。

預測期內，設備產業預期複合年成長率最高

在神經科學市場中，由於對先進和專業設備的需求不斷增加，因此預計設備領域的複合年成長率最高。此細分市場包括各種尖端設備，包括神經刺激設備、腦圖系統、神經外科設備和成像技術。神經學研究的激增以及對精確診斷和治療工具的需求推動了成長。此外，儀器技術的不斷創新促進了微創手術並提高了精確度，推動了市場擴張。

佔有率最大的地區

北美預計將主導市場並佔據神經科學市場的最大佔有率。這是由於該地區強大的醫療基礎設施、廣泛的研發活動以及神經系統疾病的高盛行率。主要市場參與企業的存在、對醫療保健的大量投資以及先進技術的實施有助於北美在神經科學市場的領導地位。此外，意識的提高和優惠的報銷政策進一步鞏固了我們在該地區的市場地位。

複合年成長率最高的地區：

由於醫療基礎設施的擴張、研究投資的增加以及神經系統疾病患者數量的快速增加，亞太地區的神經科學市場將顯著成長。醫療意識的提高、政府支持醫療進步的努力以及先進技術的採用都促進了這一成長軌跡。此外，專注於解決未滿足的醫療需求，再加上亞太地區與國際參與企業之間的合作，正在堅定地定位亞太地區。

免費客製化服務：

訂閱此報告的客戶可以利用以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與企業的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計/預測/複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 研究資訊來源
    • 主要研究資訊來源
    • 二次研究資訊來源
    • 先決條件

第3章市場趨勢分析

  • 介紹
  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球神經科學市場：依組成部分

  • 介紹
  • 裝置
  • 消耗品
  • 軟體和服務

第6章全球神經科學市場：依技術分類

  • 介紹
  • 全腦影像
    • 腦部功能影像
    • 腦部構造成像
  • 神經顯微鏡
    • 螢光神經顯微鏡
      • 共焦螢光顯微鏡
      • 螢光顯微鏡
      • TIRF螢光神經顯微鏡
      • 雙光子螢光顯微鏡
    • 電子神經顯微鏡
      • 電子斷層掃描
      • 掃描式電子神經顯微鏡
      • 透射穿透式電子顯微鏡
    • 光學神經顯微鏡
  • 電生理學
  • 神經生化偵測
  • 神經細胞的操縱
  • 神經功能可視化
  • 神經蛋白質體分析
  • 立體定位手術
    • 長期通路植入
    • 神經活性植入
    • 神經化學
  • 動物行為分析
    • C.優雅相關
    • 果蠅行為相關
    • 非人類靈長類相關
    • 光遺傳學致動器
    • 光遺傳學感測器
    • 囓齒動物行為相關
  • 其他技術

第7章 全球神經科學市場：依最終用戶分類

  • 介紹
  • 醫院
  • 診斷實驗室
  • 研究和學術機構
  • 其他最終用戶

第8章全球神經科學市場：按地區

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 中東和非洲其他地區

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Abbott Laboratories
  • ACADIA Pharmaceuticals
  • Alkermes
  • Axsome Therapeutics
  • Biogen
  • Cerevel Therapeutics
  • Cortexyme
  • Eli Lilly and Company
  • Intra-Cellular Therapies
  • Johnson & Johnson
  • Lundbeck
  • Merck & Co.
  • Neurocrine Biosciences
  • Novartis
  • Pfizer
  • Roche
  • Sage Therapeutics
  • Takeda Pharmaceutical Company
  • UCB Pharmaceuticals
  • Voyager Therapeutics
Product Code: SMRC24434

According to Stratistics MRC, the Global Neuroscience Market is accounted for $45.6 billion in 2023 and is expected to reach $75.9 billion by 2030 growing at a CAGR of 7.5% during the forecast period. Neuroscience is the multidisciplinary study of the nervous system, exploring its structure, function, development, and impact on behavior and cognition. It encompasses various fields like psychology, biology, and medicine, delving into neurons, neural circuits, and brain processes to understand perception, memory, emotions, and disorders. Neuroscience aims to decipher the complexities of the brain and nervous system, unraveling fundamental principles guiding human thought and behavior.

According to the National Center for Biotechnology Information (NCBI), each year, 22.6 million people suffer from neurological injuries or disorders, of whom 13.8 million require surgical treatment.

Market Dynamics:

Driver:

Increasing prevalence of brain-related disorders

The burgeoning prevalence of brain-related disorders acts as a catalyst, propelling the growth of the neuroscience market. With conditions like Alzheimer's, Parkinson's, and various mental health disorders on the rise, there's an amplified demand for innovative diagnostic tools, therapies, and treatments. This surge fuels extensive research, encouraging investment in neuroscience to unravel the complexities of the brain. Additionally, advanced technologies, coupled with a deeper understanding of neural mechanisms, drive the development of targeted interventions, fostering the market's expansion.

Restraint:

Expenses associated with specific instruments

Cutting-edge technologies integral to neuroscience research, such as high-resolution imaging devices, advanced electrophysiology equipment, and specialized analytical tools, often come with exorbitant costs. These financial barriers impede smaller research facilities, academic institutions, and even some industry players from accessing or affording these crucial instruments. Moreover, the cost-intensive nature of these instruments escalates the overall expenses in research and development, impacting budget allocations and potentially diverting resources from other essential areas of study.

Opportunity:

Progression in neuroscience and neuro-technological advancements

The continuous evolution and breakthroughs in neuroscience, coupled with the rapid advancement of neuro-technological innovations, present a remarkable opportunity within the neuroscience market. These progressions open avenues for groundbreaking discoveries, fostering a deeper understanding of the complexities of the brain and its functionalities. Advanced imaging techniques, brain-computer interfaces, and neuromodulation devices are among the revolutionary technologies enhancing diagnosis, treatment, and research methodologies. Such advancements not only facilitate precise mapping of neural networks but also enable more targeted interventions for neurological disorders and brain-related conditions.

Threat:

Concerns about ethics in animal experimentation

Ethical apprehensions surrounding animal experimentation pose a significant threat to the neuroscience market. Heightened societal concerns regarding the welfare and ethical implications of using animals in research can lead to stringent regulations, limitations, or even bans on certain experimental practices. This restricts the scope of research methodologies and potential avenues for understanding neural mechanisms. Such limitations can impede scientific progress, hindering the development of treatments and therapies, thereby limiting the scope and depth of neurological research and its applications within the market.

COVID-19 Impact:

The COVID-19 pandemic exerted a considerable influence on the neuroscience market. With diverted resources, disrupted research activities, and redirected focus toward combating the virus, many neuroscience projects faced delays or funding challenges. Clinical trials for neurological disorders were impacted, affecting patient recruitment and data collection. However, the pandemic also spurred innovation, emphasizing the need for telehealth solutions and accelerating digital health tools in neuroscience.

The diagnostic laboratories segment is expected to be the largest during the forecast period

The diagnostic laboratories segment is anticipated to lead the neuroscience market due to its pivotal role in advancing neurological diagnostics. These labs employ cutting-edge technologies, including genetic testing, biomarker analysis, and neuroimaging techniques like MRI and PET scans, enabling precise identification and understanding of neurological disorders. With an emphasis on early detection and personalized medicine, these labs play a crucial role in enhancing diagnostic accuracy, prognostic assessments, and therapeutic advancements. Additionally, their comprehensive testing services and research initiatives are propelling segment expansion.

The instruments segment is expected to have the highest CAGR during the forecast period

The Instruments segment is poised for the highest CAGR in the neuroscience market due to escalating demand for advanced and specialized equipment. This segment encompasses a wide array of cutting-edge devices, including neurostimulation devices, brain mapping systems, neurosurgical instruments, and imaging technologies. The surge in neurological research, coupled with the need for precise diagnostic and therapeutic tools, fuels the growth. Moreover, continuous innovation in instrument technology, fostering minimally invasive procedures and enhanced precision, drives the market's expansion.

Region with largest share:

North America is projected to dominate the market, capturing the largest share of the neuroscience market. This is attributed to the region's robust healthcare infrastructure, extensive research and development activities, and a high prevalence of neurological disorders. The presence of key market players, significant investments in healthcare, and advanced technological adoption contribute to North America's leadership in the neuroscience market. Moreover, increasing awareness and favorable reimbursement policies further solidify the region's position in the market.

Region with highest CAGR:

The Asia-Pacific region is poised for remarkable growth in the neuroscience market owing to expanding healthcare infrastructure, rising investments in research, and a burgeoning patient population with neurological disorders. Increasing awareness, government initiatives supporting healthcare advancements and the adoption of advanced technologies contribute to this growth trajectory. Additionally, a growing focus on addressing unmet medical needs, coupled with collaborations between regional and international players, positions the Asia Pacific region in a robust position.

Key players in the market:

Some of the key players in Neuroscience Market include Abbott Laboratories, ACADIA Pharmaceuticals, Alkermes, Axsome Therapeutics, Biogen, Cerevel Therapeutics, Cortexyme, Eli Lilly and Company, Intra-Cellular Therapies, Johnson & Johnson, Lundbeck, Merck & Co., Neurocrine Biosciences, Novartis, Pfizer, Roche, Sage Therapeutics, Takeda Pharmaceutical Company, UCB Pharmaceuticals and Voyager Therapeutics.

Key Developments:

In November 2023, An international team of scientists has uncovered the vital role of microglia, the immune cells in the brain that acts as its dedicated defense team, in early human brain development. By incorporating microglia into lab-grown brain organoids, scientists were able mimic the complex environment within the developing human brain to understand how microglia influence brain cell growth and development.

In September 2023, H. Lundbeck A/S (Lundbeck) announces new clinical data supporting the efficacy and tolerability of Lu AG09222 for the preventive treatment of migraine at the International Headache Congress (IHC) 2023 in Seoul, Korea. The presentations also include additional data from a proof-of-mechanism study showing that Lu AG09222 can halt PACAP38-triggered vasodilation and headaches.

In September 2023, Abbott announced it has completed the acquisition of Bigfoot Biomedical, a leader in developing smart insulin management systems for people with diabetes. The transaction expands Abbott's presence in diabetes care, building on its world-leading FreeStyle Libre® portfolio of continuous glucose monitoring technology and furthering the company's efforts to develop connected solutions for making diabetes management even more personal and precise.

Components Covered:

  • Instruments
  • Consumables
  • Software and Services

Technologies Covered:

  • Whole Brain Imaging
  • Neuro-Microscopy
  • Electrophysiology
  • Neuro Biochemical Assays
  • Neurocellular Manipulation
  • Neurofunctional Visualization
  • Neuroproteomic Analysis
  • Stereotaxic Surgeries
  • Animal Behavior Analysis
  • Other Technologies

End Users Covered:

  • Hospitals
  • Diagnostic Laboratories
  • Research and Academic Institutes
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.6 Research Sources
    • 2.6.1 Primary Research Sources
    • 2.6.2 Secondary Research Sources
    • 2.6.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neuroscience Market, By Component

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Consumables
  • 5.4 Software and Services

6 Global Neuroscience Market, By Technology

  • 6.1 Introduction
  • 6.2 Whole Brain Imaging
    • 6.2.1 Functional Brain Imaging
    • 6.2.2 Structural Brain Imaging
  • 6.3 Neuro-Microscopy
    • 6.3.1 Fluoroscence Neuro-Microscopy
      • 6.3.1.1 Confocal Fluoroscence Microscopy
      • 6.3.1.2 Epifluorescent Fluoroscence Microscopy
      • 6.3.1.3 TIRF Fluoroscence Neuro-Microscopy
      • 6.3.1.4 Two-Photon Fluoroscence Microscopy
    • 6.3.2 Electron Neuro-Microscopy
      • 6.3.2.1 Electron Tomography
      • 6.3.2.2 Scanning electron Neuro-Microscopy
      • 6.3.2.3 Transmission Electron Neuro-Microscopy
    • 6.3.3 Light Neuro-Microscopy
  • 6.4 Electrophysiology
  • 6.5 Neuro Biochemical Assays
  • 6.6 Neurocellular Manipulation
  • 6.7 Neurofunctional Visualization
  • 6.8 Neuroproteomic Analysis
  • 6.9 Stereotaxic Surgeries
    • 6.9.1 Long-Term Access Implants
    • 6.9.2 Neural Activity Implants
    • 6.9.3 Neurochemistry
  • 6.10 Animal Behavior Analysis
    • 6.10.1 C.Elegans Related
    • 6.10.2 Drosophila Behavior Related
    • 6.10.3 Non-Human Primates Related
    • 6.10.4 Optogenetics Actuators
    • 6.10.5 Optogenetics Sensors
    • 6.10.6 Rodent Behavior Related
  • 6.11 Other Technologies

7 Global Neuroscience Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Diagnostic Laboratories
  • 7.4 Research and Academic Institutes
  • 7.5 Other End Users

8 Global Neuroscience Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.6 South America
    • 8.6.1 Argentina
    • 8.6.2 Brazil
    • 8.6.3 Chile
    • 8.6.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Abbott Laboratories
  • 10.2 ACADIA Pharmaceuticals
  • 10.3 Alkermes
  • 10.4 Axsome Therapeutics
  • 10.5 Biogen
  • 10.6 Cerevel Therapeutics
  • 10.7 Cortexyme
  • 10.8 Eli Lilly and Company
  • 10.9 Intra-Cellular Therapies
  • 10.10 Johnson & Johnson
  • 10.11 Lundbeck
  • 10.12 Merck & Co.
  • 10.13 Neurocrine Biosciences
  • 10.14 Novartis
  • 10.15 Pfizer
  • 10.16 Roche
  • 10.17 Sage Therapeutics
  • 10.18 Takeda Pharmaceutical Company
  • 10.19 UCB Pharmaceuticals
  • 10.20 Voyager Therapeutics

List of Tables

  • Table 1 Global Neuroscience Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neuroscience Market Outlook, By Component (2021-2030) ($MN)
  • Table 3 Global Neuroscience Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global Neuroscience Market Outlook, By Consumables (2021-2030) ($MN)
  • Table 5 Global Neuroscience Market Outlook, By Software and Services (2021-2030) ($MN)
  • Table 6 Global Neuroscience Market Outlook, By Technology (2021-2030) ($MN)
  • Table 7 Global Neuroscience Market Outlook, By Whole Brain Imaging (2021-2030) ($MN)
  • Table 8 Global Neuroscience Market Outlook, By Functional Brain Imaging (2021-2030) ($MN)
  • Table 9 Global Neuroscience Market Outlook, By Structural Brain Imaging (2021-2030) ($MN)
  • Table 10 Global Neuroscience Market Outlook, By Neuro-Microscopy (2021-2030) ($MN)
  • Table 11 Global Neuroscience Market Outlook, By Fluoroscence Neuro-Microscopy (2021-2030) ($MN)
  • Table 12 Global Neuroscience Market Outlook, By Confocal Fluoroscence Microscopy (2021-2030) ($MN)
  • Table 13 Global Neuroscience Market Outlook, By Epifluorescent Fluoroscence Microscopy (2021-2030) ($MN)
  • Table 14 Global Neuroscience Market Outlook, By TIRF Fluoroscence Neuro-Microscopy (2021-2030) ($MN)
  • Table 15 Global Neuroscience Market Outlook, By Two-Photon Fluoroscence Microscopy (2021-2030) ($MN)
  • Table 16 Global Neuroscience Market Outlook, By Electron Neuro-Microscopy (2021-2030) ($MN)
  • Table 17 Global Neuroscience Market Outlook, By Electron Tomography (2021-2030) ($MN)
  • Table 18 Global Neuroscience Market Outlook, By Scanning electron Neuro-Microscopy (2021-2030) ($MN)
  • Table 19 Global Neuroscience Market Outlook, By Transmission Electron Neuro-Microscopy (2021-2030) ($MN)
  • Table 20 Global Neuroscience Market Outlook, By Light Neuro-Microscopy (2021-2030) ($MN)
  • Table 21 Global Neuroscience Market Outlook, By Electrophysiology (2021-2030) ($MN)
  • Table 22 Global Neuroscience Market Outlook, By Neuro Biochemical Assays (2021-2030) ($MN)
  • Table 23 Global Neuroscience Market Outlook, By Neurocellular Manipulation (2021-2030) ($MN)
  • Table 24 Global Neuroscience Market Outlook, By Neurofunctional Visualization (2021-2030) ($MN)
  • Table 25 Global Neuroscience Market Outlook, By Neuroproteomic Analysis (2021-2030) ($MN)
  • Table 26 Global Neuroscience Market Outlook, By Stereotaxic Surgeries (2021-2030) ($MN)
  • Table 27 Global Neuroscience Market Outlook, By Long-Term Access Implants (2021-2030) ($MN)
  • Table 28 Global Neuroscience Market Outlook, By Neural Activity Implants (2021-2030) ($MN)
  • Table 29 Global Neuroscience Market Outlook, By Neurochemistry (2021-2030) ($MN)
  • Table 30 Global Neuroscience Market Outlook, By Animal Behavior Analysis (2021-2030) ($MN)
  • Table 31 Global Neuroscience Market Outlook, By C.Elegans Related (2021-2030) ($MN)
  • Table 32 Global Neuroscience Market Outlook, By Drosophila Behavior Related (2021-2030) ($MN)
  • Table 33 Global Neuroscience Market Outlook, By Non-Human Primates Related (2021-2030) ($MN)
  • Table 34 Global Neuroscience Market Outlook, By Optogenetics Actuators (2021-2030) ($MN)
  • Table 35 Global Neuroscience Market Outlook, By Optogenetics Sensors (2021-2030) ($MN)
  • Table 36 Global Neuroscience Market Outlook, By Rodent Behavior Related (2021-2030) ($MN)
  • Table 37 Global Neuroscience Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 38 Global Neuroscience Market Outlook, By End User (2021-2030) ($MN)
  • Table 39 Global Neuroscience Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 40 Global Neuroscience Market Outlook, By Diagnostic Laboratories (2021-2030) ($MN)
  • Table 41 Global Neuroscience Market Outlook, By Research and Academic Institutes (2021-2030) ($MN)
  • Table 42 Global Neuroscience Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.